Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease (Q45299599)

11 December 2017

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease (English)

1 reference

11 December 2017

0 references

Véronique M André

1

1 reference

11 December 2017

Carlos Cepeda

2

1 reference

11 December 2017

Angela Venegas

3

1 reference

11 December 2017

Yeranui Gomez

4

1 reference

11 December 2017

Michael S Levine

5

1 reference

11 December 2017

language of work or name

English

0 references

publication date

28 December 2005

1 reference

Journal of Neurophysiology

11 December 2017

1 reference

11 December 2017

95

1 reference

11 December 2017

2108-2119

1 reference

11 December 2017

4

1 reference

Sensorimotor integration in movement disorders

11 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6/2 mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

The role of NMDA receptors in long-term potentiation (LTP) and depression (LTD) in rat visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Long-term regulation of excitatory and inhibitory synaptic transmission in hippocampal cultures by brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

NMDA receptor function in mouse models of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Impaired learning-dependent cortical plasticity in Huntington's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Excitotoxic injury of the neostriatum: a model for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Frontal-striatal disconnection disrupts cognitive performance of the frontal-type in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Cortical and striatal neurone number in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Cloned glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

NMDA-Receptor-Independent Long-Term Potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Development of Neuropsychological Deficits in Huntington's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Correlation between kinetics and RNA splicing of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in neocortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

A glutamatergic corticostriatal path?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Brain-derived neurotrophic factor regulates the expression of AMPA receptor proteins in neocortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Huntington disease: new insights into the relationship between CAG expansion and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Evoked potentials in patients with Huntington's disease and their offspring. I. Somatosensory evoked potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

AMPA receptor potentiators for the treatment of CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Structural determinants of allosteric regulation in alternatively spliced AMPA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Expression of the Huntington's disease (IT15) protein product in HD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Abnormalities of somatosensory evoked potentials in the quinolinic acid model of Huntington's disease: evidence that basal ganglia modulate sensory cortical input

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Early onset Huntington disease: a neuronal degeneration syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Neocortical neurons cultured from mice with expanded CAG repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Absence of frontal somatosensory evoked potentials in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Glutamate receptor expression in rat striatum: effect of deafferentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

Determination of NMDA NR1 subunit copy number in recombinant NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.01118.2005

21 January 2018

Identifiers

DOI

10.1152/JN.01118.2005

1 reference

11 December 2017

1 reference